- Health & Pharmaceuticals›
- Physicians, Hospitals & Pharmacies›
Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)
by John Elflein,
last edited
Jan 30, 2018
This statistic depicts the average hospital charges and costs per inpatient HSC transplant patient under Medicaid in 2014, by procedure. According to the data, for a cord blood stem cell transplant under Medicaid, hospital charges were 987,339 U.S. dollars on average and the cost per inpatient stay stood at 296,896 US dollars on average.
Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)
| Charges | Costs | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| Charges | Costs | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by John Elflein,
last edited
Jan 30, 2018
This statistic depicts the average hospital charges and costs per inpatient HSC transplant patient under Medicaid in 2014, by procedure. According to the data, for a cord blood stem cell transplant under Medicaid, hospital charges were 987,339 U.S. dollars on average and the cost per inpatient stay stood at 296,896 US dollars on average.
- Show sources information
- Show publisher information
- Release date
- September 2017
- Region
- United States
- Survey time period
- 2014
Source
- Show sources information
- Show publisher information
- Release date
- September 2017
More information
- Region
- United States
- Survey time period
- 2014
Other statistics on the topic
+Pharmaceutical Products & Market
Global cell and gene therapy market forecast 2012-2020
+Pharmaceutical Products & Market
Global stem cell market size forecast 2025
+Pharmaceutical Products & Market
Regenerative medicine companies by world region 2019
+Health System
View of increasing government funding for stem cell research - U.S. adults 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Cell and gene therapy
- 72 page/s
- English
- pptx
- Detailed references
Everything On "Cell and gene therapy" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Cell and gene therapy"
- Market overview
The most important statistics
- Projected global market size for regenerative medicine from 2016 to 2025 (in billion euros)Global market size for regenerative medicine from 2016-2025
- Global cell and gene therapy market forecast between 2012 and 2020 (in billion U.S. dollars)Global cell and gene therapy market forecast 2012-2020
- Global cell culture market size from 2012 to 2022 (in million U.S. dollars)Global cell culture market size 2012-2022
- Distribution of advanced therapy medicinal products (ATMP) by classification worldwide as of 2016ATMP classification share worldwide 2016
- Distribution of regenerative medicine companies by world region as of 2019*Regenerative medicine companies by world region 2019
- Market capitalization of selected larger gene and cell therapy companies in the U.S. as of 2017 (in billion U.S. dollars)*Market cap of larger gene and cell therapy companies in U.S. as of 2017
- R&D/trials
The most important statistics
- Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phaseATMP trials classification share by disease and development phase globally 2016
- Distribution of advanced therapy medicinal product (ATMP) clinical trials by type of sponsor worldwide as of 2016ATMP clinical trials share globally by type of sponsor
- Distribution of non-commercial advanced therapy medicinal product (ATMP) trials by sponsor worldwide as of 2016ATMP clinical trials non-commercial sponsors distribution globally 2016
- Number of stem-cell and gene therapies in current development as of 2017, by developerNumber of biotech therapies in development as of 2017, by developer
- Percentage of stem-cell and gene therapies in current development as of 2017, by developerPercentage of biotech therapies in development as of 2017, by developer
- Stem cells
The most important statistics
- Global stem cell market size by world region between 2011 and 2016 (in billion U.S. dollars)*Global stem cell market size by world region 2011-2016
- Distribution of the stem cell technologies and applications market by world region in 2016Stem cell technologies and applications market share by world region 2016
- Global stem cell market size in 2016 and a forecast for 2025 (in billion U.S. dollars)*Global stem cell market size forecast 2025
- Number of hematopoietic stem cell (HSC) transplants in the United States from 2010 to 2015, by sourceNumber of HSC transplants in the US from 2010-2015, by source
- Total stem cell research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2018 (in million U.S. dollars)Total stem cell research funding by the National Institutes for Health 2013-2018
- Cord blood
The most important statistics
- Aggregate annual demand of cord blood units (CBUs) in the U.S. from 2010 to 2016*Aggregate annual demand for cord blood units from 2010-2016
- Average annual social value of the U.S. cord blood bank system based on donor/patient matching from 2010 to 2016 (in million U.S. dollars) Annual social value of U.S. CBB system by scenario 2010-2016
- Percentage of cord blood units (CBUs) from the U.S. shipped to domestic and international destinations from 2010 to 2016Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
- Share of U.S. cord blood units (CBUs) shipped by the U.S. by total nucleated cell count (TNC) from 2002 to 2016Percentage of shipped U.S. cord blood units by TNC count 2002-2016
- Share of U.S. cord blood units (CBUs) stored by total nucleated cell count (TNC) from 2002 to 2016Percentage of stored U.S. CBUs by TNC count 2002-2016
- CAR/CAR-T
The most important statistics
- Number of CAR cell therapy trials worldwide from 2007 to 2016*Number of CAR cell therapy trials worldwide 2007-2016
- Number of CAR cell therapy trials, comparing the U.S. and China from 2009 to 2016*Number of CAR cell therapy trials U.S. vs China 2009-2016
- Venture capital funding for select companies involved in CAR-T programs between 2011 and 2016 (in million U.S. dollars)*Venture capital funding for companies in CAR-T programs 2011-2016
- Selected IPOs of companies with a CAR-T focus between 2013 and 2015 (in million U.S. dollars)*IPO value of select CAR-T companies 2013-2015
- Miscellaneous
The most important statistics
- Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedureLength of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
- Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Price of select market-stage advanced therapy medicinal products (ATMPs) as of 2016 (in U.S. dollars)Select market-stage ATMPs price in the U.S. as of 2016
- Do you favor or oppose expanding federal funding for research using embryonic stem cells?View of increasing government funding for stem cell research - U.S. adults 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Hospital costs for an HSC transplant in the U.S. in 2014, by procedure
- Medicare charges and costs for an HSC transplant in 2014, by procedure
- Hospital charges for an HSC transplant in the U.S. in 2014, by procedure
- Cost of inpatient day at hospitals in the U.S. 2016 by type
- Opioid-related inpatient stays with Medicaid U.S. 2010 and 2015, by state
- Most expensive conditions billed to Medicaid in U.S. hospitals 2013
- Annual inpatient charges for Medicaid type 2 diabetes patients 2016
- Decrease in unpaid hospital bills under Medicaid expansion APril 2015
- Number of HSC transplants in the US from 2010-2015
- Number of HSC transplants in the US from 2010-2016, by condition and source
- Number of HSC transplants in the US from 2010-2016, by condition
- Overall inpatient experience in Northern Ireland 2013, by gender
- Rating of overall inpatient care in Northern Ireland 2013, by gender
- Route of admission as an inpatient in Northern Ireland 2013, by gender
- opioid-related inpatient stay rates by state in U.S. 2014
- Inpatient curative and rehabilitative care: GDP expenditure in Sweden 2003-2013
- Health expenditure on inpatient curative and rehabilitative care in Poland 2005-2015
- Distribution of Canadian hospital expenditures in 2017 to 2018, by functional area
- Health expenditure on inpatient curative and rehabilitative care in Sweden 2003-2013
- Inpatient curative and rehabilitative care: GDP expenditure in Finland 2003-2013
Studies
- Hospitals in Germany
- Hospitals in Canada
- Doctors in Germany
- Components of Growth in Inpatient Hospital Costs, 1997–2009
- Medicaid Hospitalizations, 2008
- Program Information on Medicaid & State Children's Health Insurance Program (SCHIP)
- Trend in Psychiatric Inpatient Capacity, United States and Each State, 1970 to 2014
- 2014 Physician Appointment Wait Times and Medicaid and Medicare Acceptance Rates
- Massachusetts Health Care Cost Trends 2018
- Massachusetts Hospital Profiles - Data Through Fiscal Year 2017
- Hospital Admitted Patient Care and Adult Critical Care Activity 2017-18
- Asthma Hospitalizations Among Children and Youth in Canada (2018)
- Massachusetts Health Care Cost Trends 2017
- Massachusetts Hospital Profiles - Data Through Fiscal Year 2016
- The National Hospital Bill: The Most Expensive Conditions by Payer, 2008
Statistics on "Cell and gene therapy"
- Global market size for regenerative medicine from 2016-2025
- Global cell and gene therapy market forecast 2012-2020
- Global cell culture market size 2012-2022
- ATMP classification share worldwide 2016
- Regenerative medicine companies by world region 2019
- Market cap of larger gene and cell therapy companies in U.S. as of 2017
- ATMP trials classification share by disease and development phase globally 2016
- ATMP clinical trials share globally by type of sponsor
- ATMP clinical trials non-commercial sponsors distribution globally 2016
- Number of biotech therapies in development as of 2017, by developer
- Percentage of biotech therapies in development as of 2017, by developer
- Global stem cell market size by world region 2011-2016
- Stem cell technologies and applications market share by world region 2016
- Global stem cell market size forecast 2025
- Number of HSC transplants in the US from 2010-2015, by source
- Total stem cell research funding by the National Institutes for Health 2013-2018
- Aggregate annual demand for cord blood units from 2010-2016
- Annual social value of U.S. CBB system by scenario 2010-2016
- Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
- Percentage of shipped U.S. cord blood units by TNC count 2002-2016
- Percentage of stored U.S. CBUs by TNC count 2002-2016
- Number of CAR cell therapy trials worldwide 2007-2016
- Number of CAR cell therapy trials U.S. vs China 2009-2016
- Venture capital funding for companies in CAR-T programs 2011-2016
- IPO value of select CAR-T companies 2013-2015
- Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
- Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
- Capital raised by regenerative medicine companies worldwide 2016-2018
- Select market-stage ATMPs price in the U.S. as of 2016
- View of increasing government funding for stem cell research - U.S. adults 2017
- Hospital costs for an HSC transplant in the U.S. in 2014, by procedure
- Medicare charges and costs for an HSC transplant in 2014, by procedure
- Hospital charges for an HSC transplant in the U.S. in 2014, by procedure
- Cost of inpatient day at hospitals in the U.S. 2016 by type
- Opioid-related inpatient stays with Medicaid U.S. 2010 and 2015, by state
- Most expensive conditions billed to Medicaid in U.S. hospitals 2013
- Annual inpatient charges for Medicaid type 2 diabetes patients 2016
- Decrease in unpaid hospital bills under Medicaid expansion APril 2015
- Number of HSC transplants in the US from 2010-2015
- Number of HSC transplants in the US from 2010-2016, by condition and source
- Number of HSC transplants in the US from 2010-2016, by condition
- Overall inpatient experience in Northern Ireland 2013, by gender
- Rating of overall inpatient care in Northern Ireland 2013, by gender
- Route of admission as an inpatient in Northern Ireland 2013, by gender
- opioid-related inpatient stay rates by state in U.S. 2014
- Inpatient curative and rehabilitative care: GDP expenditure in Sweden 2003-2013
- Health expenditure on inpatient curative and rehabilitative care in Poland 2005-2015
- Distribution of Canadian hospital expenditures in 2017 to 2018, by functional area
- Health expenditure on inpatient curative and rehabilitative care in Sweden 2003-2013
- Inpatient curative and rehabilitative care: GDP expenditure in Finland 2003-2013
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.